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atcliffe and colleagues have made an important contribution about the state
of research for cardiothoracic surgeons (see page 392). They have appropri-
ately concluded that per capita funding by the National Institutes of Health
(NIH) for cardiothoracic surgeons is less than that of the NIH as a whole. They have
done a very careful analysis of the reasons for this. The bottom line is that there are
two major issues.
The first is that there had been a change related to grant review in that surgical
grants were reallocated to nonsurgical study sections. The concept here was to have
more disease-oriented study sections. In practice, this meant that clinical investigators
would not get appropriate peer review. Cardiothoracic surgical research is truly
translational research. It takes basic science principles and applies them to the clin-
ical realm. Appropriate peer review comprises surgeons who see and study these
clinical problems and know the importance of such applications. Because of this
reorganization, surgical grants tended to fair poorly in these nonsurgical study sec-
tions. Through the efforts of the Scientific Affairs Committee of The American As-
sociation for Thoracic Surgery (AATS), this has been addressed with the NIH
leadership. Surgeons will now be allowed to request appropriate study sections if
indeed the study section requested review such grants in general. I believe this
will make a large difference.
The second issue that the authors have raised is a more difficult one. The problem
here is that there are fewer grants being submitted. The authors have suggested that
there should be some affirmative action from the NIH to encourage research from
cardiothoracic surgeons. In fact, there is a great concern at the NIH about the loss
of clinical investigators in general. I think the problem here is more than just one
for the NIH, but also for the leadership of cardiothoracic surgery as a whole. This
is perhaps the major issue facing us. If there is no scientific investigation by our future
faculty, then there will no new technology or advances in our field. Our specialty will
stagnate and eventually whither away. I would suggest that this should be a major
focus for the thoracic surgical leadership.
The AATS has plans to focus on the development of academic surgeons. These
will need to be amplified. Appropriate mentorship for clinical investigators is the
most difficult issue facing surgical division and department chairs. The balance be-
tween clinical work and scientific investigation is very difficult to achieve. As a mat-
ter of fact, this was the major issue discussed at the new members’ luncheon at the
recent AATS meeting. There is a tremendous emphasis for young faculty members
to develop clinical surgical careers. To develop a clinical reputation, one must oper-
ate and achieve good results. This is in stark contrast to the needs of the basic
science investigator. Indeed, those individuals in basic science departments are
full-time investigators and have time to develop their research careers. Therefore,
how will this balance be met? For our specialty to develop clinical investigators,
we must provide the resources to protect them at least at the beginning of their ac-
ademic careers while they are developing scientific cooperations. They must learn
how to run a laboratory as well as get grant funding. Just protecting time is not
enough. Senior leadership of departments and divisions must guarantee that these
individuals use the time to develop their scientific careers. To help them to develop
their clinical careers at the same time, we must provide them with cases and support
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Kron Evolving Technologyso that the balance can be met. For some institutions this is
easier than for others. Not all institutions are able to provide
young investigators appropriate scientific and clinical men-
toring. Therefore, our national organizations will somehowhave to develop a method for mentoring to occur on a
national level.
I must congratulate the authors for bringing this major issue
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